International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem.

  • Allergy and Clinical Immunology
April 18, 2017 By:
  • Sánchez-Borges M
  • Fernandez-Caldas E
  • Thomas WR
  • Chapman MD
  • Lee BW
  • Caraballo L
  • Acevedo N
  • Chew FT
  • Ansotegui IJ
  • Behrooz L
  • Phipatanakul W
  • Gerth van Wijk R
  • Pascal D
  • Rosario N
  • Ebisawa M
  • Geller M
  • Quirce S
  • Vrtala S
  • Valenta R
  • Ollert M
  • Canonica GW
  • Calderón MA
  • Barnes CS
  • Custovic A
  • Benjaponpitak S
  • Capriles-Hulett A.

Since mite allergens are the most relevant inducers of allergic diseases worldwide, resulting in significant morbidity and increased burden on health services, the International Collaboration in Asthma, Allergy and Immunology (iCAALL), formed by the American Academy of Allergy, Asthma and Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI), and the World Allergy Organization (WAO), has proposed to issue an International Consensus (ICON) on the clinical consequences of mite hypersensitivity. The objectives of this document are to highlight aspects of mite biology that are clinically relevant, to update the current knowledge on mite allergens, routes of sensitization, the genetics of IgE responses to mites, the epidemiologic aspects of mite hypersensitivity, the clinical pictures induced by mites, the diagnosis, specific immunotherapeutic approaches, and prevention.

2017 Apr. World Allergy Organ J.10(1):14.
Other information